T-cells comprising anti-CD38 and anti-CD138 chimeric antigen receptors and uses thereof Grant US-11944644-B2 United States of America 02 Apr 2024
Blockade of CD7 expression and chimeric antigen receptors for immunotherapy of T-cell… Grant US-11945865-B2 United States of America 02 Apr 2024
Receptors providing targeted costimulation for adoptive cell therapy Grant US-11945876-B2 United States of America 02 Apr 2024
Dual chimeric antigen receptor-t cell which can be regulated, construction method… Grant US-11932872-B2 United States of America 19 Mar 2024
NOVEL DUAL SPLIT CAR-T CELLS FOR THE TREATMENT OF CD38-POSITIVE HEMATOLOGICAL MALIGNANCIES Application WO-2024052318-A1 World Intellectual Property Organisation (WIPO) 14 Mar 2024
Nucleic acid molecules encoding chimeric antigen receptors comprising a CD20 binding… Grant US-RE49847-E1 United States of America 27 Feb 2024
T cells containing anti-CD38 and anti-CD138 chimeric antigen receptors and their uses Grant JP-7437705-B2 Japan 26 Feb 2024
Method of treating cancer by administering immune effector cells expressing a chimeric… Grant US-11872249-B2 United States of America 16 Jan 2024
Devices and methods for isolating tumor infiltrating lymphocytes and uses thereof Grant US-11767510-B2 United States of America 26 Sep 2023
Chimeric molecules providing targeted costimulation for adoptive cell therapy Grant US-11697677-B2 United States of America 11 Jul 2023
Methods for enhancing efficacy of therapeutic immune cells Grant US-11679132-B2 United States of America 20 Jun 2023
Universal platform for preparing an inhibitory chimeric antigen receptor (iCAR) Grant US-11660315-B2 United States of America 30 May 2023
T cell receptor-deficient chimeric antigen receptor T-cells and methods of use thereof Grant US-11648269-B2 United States of America 16 May 2023
Aseptic tissue processing method, kit and device Grant US-11618877-B2 United States of America 04 Apr 2023
Aseptic tissue processing method, kit and device Grant US-11618878-B2 United States of America 04 Apr 2023
Compositions and methods for treating mesothelin positive cancers Grant US-11602543-B2 United States of America 14 Mar 2023
Compositions and methods for treating EGFR positive cancers Grant US-11602544-B2 United States of America 14 Mar 2023
Methods and compositions relating to chimeric antigen receptors Grant US-11530252-B2 United States of America 20 Dec 2022
RECEPTORS PROVIDING TARGETED COSTIMULATION FOR ADOPTIVE CELL THERAPY Application US-20220348631-A1 United States of America 03 Nov 2022
Blockade of CD7 expression and chimeric antigen receptors for immunotherapy of T-cell… Grant US-11440958-B2 United States of America 13 Sep 2022
Compositions and methods for treating ceacam positive cancers Grant US-11433100-B2 United States of America 06 Sep 2022
CHIMERIC ANTIGEN RECEPTOR COMPRISING AN ANTIGEN BINDING DOMAIN SPECIFIC FOR MSLN HAVING A… Application WO-2022096425-A3 World Intellectual Property Organisation (WIPO) 30 Jun 2022
Methods for enhancing efficacy of therapeutic immune cells Grant AU-2016216149-B2 Australia 31 Mar 2022
COMPOSITIONS AND METHODS FOR TREATING CANCER EXPRESSING CD90 AND CD326 Application WO-2021234006-A1 World Intellectual Property Organisation (WIPO) 25 Nov 2021
T-CELLS COMPRISING TWO DIFFERENT CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF Application EP-3720882-A4 European Patent Office 27 Oct 2021
T cell which co-expresses a CD19 chimeric antigen receptor and a CD22 chimeric antigen… Grant US-11091532-B2 United States of America 17 Aug 2021
Compositions and methods for treating cancer with anti-BCMA immunotherapy Grant US-11052112-B2 United States of America 06 Jul 2021
DOUBLE-TARGET CHIMERIC ANTIGEN RECEPTOR FOR SIMULTANEOUSLY TARGETING MESOTHELIN AND FAP… Application WO-2021120526-A1 World Intellectual Property Organisation (WIPO) 24 Jun 2021
Chimeric antigen receptor (CAR) comprising a CD19-binding domain Grant US-11034750-B2 United States of America 15 Jun 2021
Chimeric antigen receptor (CAR) comprising a CD22-binding domain Grant US-10981970-B2 United States of America 20 Apr 2021
Modified T cell comprising a polynucleotide encoding an inducible stimulating molecule… Grant US-10934346-B2 United States of America 02 Mar 2021
Costimulation of chimeric antigen receptors by MYD88 and CD40 polypeptides Grant US-10918705-B2 United States of America 16 Feb 2021
Costimulation of chimeric antigen receptors by MyD88 and CD40 polypeptides Grant US-10888608-B2 United States of America 12 Jan 2021
Methods for enhancing efficacy of therapeutic immune cells Grant US-10765699-B2 United States of America 08 Sep 2020
RECEPTORS PROVIDING TARGETED COSTIMULATION FOR ADOPTIVE CELL THERAPY Application WO-2020152451-A1 World Intellectual Property Organisation (WIPO) 30 Jul 2020
NEW DUAL CHIMERIC ANTIGEN RECEPTOR-T CELL WHICH CAN BE REGULATED, CONSTRUCTION METHOD… Application US-20200224162-A1 United States of America 16 Jul 2020
Method to treat cancer with engineered T-cells Grant US-10639329-B2 United States of America 05 May 2020
A GROUP OF CHIMERIC ANTIGEN RECEPTORS (CARS) Application WO-2020070290-A1 World Intellectual Property Organisation (WIPO) 09 Apr 2020
A GROUP OF CHIMERIC ANTIGEN RECEPTORS (CARS) Application WO-2020070289-A1 World Intellectual Property Organisation (WIPO) 09 Apr 2020
A GROUP OF CHIMERIC ANTIGEN RECEPTORS (CARS) Application EP-3632461-A1 European Patent Office 08 Apr 2020
A GROUP OF CHIMERIC ANTIGEN RECEPTORS (CARS) Application EP-3632460-A1 European Patent Office 08 Apr 2020
Chimeric antigen receptor signalling system comprising heterodimerization domains Grant US-10604570-B2 United States of America 31 Mar 2020
Blockade of CD7 expression and chimeric antigen receptors for immunotherapy of T-cell… Grant US-10550183-B2 United States of America 04 Feb 2020
Compositions and methods for treating cancer with anti-mesothelin immunotherapy Grant US-10550179-B2 United States of America 04 Feb 2020
HETERODIMERIC INACTIVATABLE CHIMERIC ANTIGEN RECEPTORS Application WO-2019197676-A1 World Intellectual Property Organisation (WIPO) 17 Oct 2019
NON-CYTOTOXIC MODIFIED CELLS AND USE THEREOF Application US-20190233516-A1 United States of America 01 Aug 2019
BIPARTITE AND TRIPARTITE SIGNALING IMMUNE CELLS Application EP-3489362-A1 European Patent Office 29 May 2019
Compositions and methods for treating cancer with anti-mesothelin immunotherapy Grant US-10183993-B2 United States of America 22 Jan 2019
BIPARTITE AND TRIPARTITE SIGNALING IMMUNE CELLS Application EP-3207147-A4 European Patent Office 27 Jun 2018
Methods for controlling T cell proliferation Grant US-9944690-B2 United States of America 17 Apr 2018
NOVEL RECOMBINASES AND TARGET SEQUENCES Application WO-2017127612-A1 World Intellectual Property Organisation (WIPO) 27 Jul 2017
THERAPEUTIC AGENTS Application WO-2017021701-A1 World Intellectual Property Organisation (WIPO) 09 Feb 2017
CHIMERIC ANTIGEN RECEPTORS (CARs), COMPOSITIONS AND METHODS OF USE THEREOF Application WO-2016210293-A1 World Intellectual Property Organisation (WIPO) 29 Dec 2016
NUCLEIC ACID CONSTRUCT FOR EXPRESSING MORE THAN ONE CHIMERIC ANTIGEN RECEPTOR Application WO-2016174406-A1 World Intellectual Property Organisation (WIPO) 03 Nov 2016
METHODS FOR ENHANCING EFFICACY OF THERAPEUTIC IMMUNE CELLS Application WO-2016126213-A1 World Intellectual Property Organisation (WIPO) 11 Aug 2016